Tesamorelin 5mg Research Peptide
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), commonly utilized in laboratory research involving growth hormone signaling pathways, receptor interactions, and neuroendocrine communication studies. Researchers investigate Tesamorelin in experimental models examining peptide-mediated biological processes and cellular signaling mechanisms.
This product is intended strictly for laboratory research purposes, not for human consumption, therapeutic use, veterinary use, or diagnostic use.
Specifications
| Compound | Tesamorelin 5mg |
|---|---|
| Category | Peptide |
| SKU | GRL-Tesamorelin-5mg |
| Unit size | 5 mg |
| Price | $40.00 |
| Availability | In stock |
| Intended use | Laboratory research use only |
Compound identity
Reference facts for the compound itself, from PubChem (NIH). They describe the molecule, not a specific batch — batch purity is reported on the certificate of analysis.
| CAS Registry Number | 218949-48-5 |
|---|---|
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5136 g/mol |
| PubChem CID | 16137828 |
Tesamorelin 5mg is also written Tesamorelin peptide.
Research Applications
- Growth hormone signaling research
- GHRH receptor studies
- Neuroendocrine pathway investigations
- Peptide interaction research
- Laboratory-based biological studies
Product Specifications
- Contents: Tesamorelin
- Quantity: 5 mg per vial
- Appearance: Lyophilized powder
- Storage: Refrigerate upon receipt
- Research use only
Research questions about this compound
Does tesamorelin directly burn fat?
The research indicates that tesamorelin reduces visceral adipose tissue in specific clinical populations, likely through the lipolytic effects mediated by increased endogenous growth hormone . It is not described in the literature as a direct "fat burner" in the way thermogenic compounds are, but rather as a modulator of body composition via the endocrine system .
How does tesamorelin differ from growth hormone injections?
Tesamorelin is a GHRH analog that stimulates the pituitary gland to produce the body’s own growth hormone, whereas direct GH therapy introduces exogenous hormone into the system . Clinical research suggests this approach may help maintain more natural pulsatile secretion patterns, though both methods result in elevated serum GH levels .
Is tesamorelin safe for long-term use?
Clinical trials have monitored participants for up to 52 weeks, documenting side effects such as joint pain and changes in glucose metabolism , . Long-term safety beyond these clinical windows remains an area of ongoing research, and current prescribing information emphasizes the need for regular monitoring of metabolic markers .
Does tesamorelin improve insulin sensitivity?
Actually, the research often highlights the opposite; in human trials, tesamorelin has been associated with increases in fasting glucose and HbA1c, suggesting a potential for decreased insulin sensitivity during the course of administration , .
labels, lab notebooks, reorders
Tesamorelin 5mg — Reconstitution Calculator
For laboratory research use only. This tool computes the concentration of a reconstituted research solution and the volume that contains a target mass. Vial mass is a product specification, not a dose. It is not medical guidance and does not describe administration to humans or animals.
For laboratory research use only · not for human or animal use. Doses-per-bottle is pure arithmetic (vial mass ÷ target amount), not a dosing recommendation.
